Article de Périodique
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study (2016)
Auteur(s) :
T. SCHOELER ;
N. PETROS ;
M. DI FORTI ;
E. KLAMERUS ;
E. FOGLIA ;
O. AJNAKINA ;
C. GAYER-ANDERSON ;
M. COLIZZI ;
D. QUATTRONE ;
I. BEHLKE ;
S. SHETTY ;
P. McGUIRE ;
A. S. DAVID ;
R. MURRAY ;
S. BHATTACHARYYA
Article en page(s) :
947-953
Refs biblio. :
25
Domaine :
Drogues illicites / Illicit drugs
Langue(s) :
Anglais
Discipline :
PSY (Psychopathologie / Psychopathology)
Thésaurus mots-clés
TROUBLE BIPOLAIRE
;
CANNABIS
;
PSYCHOSE
;
RECHUTE
;
TYPE D'USAGE
;
EFFET SECONDAIRE
;
FACTEUR DE RISQUE
Thésaurus géographique
ROYAUME-UNI
Note générale :
Comment: RABIN R.A., GEORGE T.P. Cannabis and psychosis: understanding the smoke signals. The Lancet Psychiatry, 2016; 3(10): p. 909-910.
Résumé :
ENGLISH:
Background: Although cannabis use after a first episode of psychosis has been associated with relapse, little is known about the determinants of this most preventable risk factor for relapse of psychosis. Here we aimed to study whether the effects on outcome vary depending on the type of cannabis consumed and usage pattern.
Methods: In this observational study, we prospectively recruited and followed up patients aged 18-65 years who presented with their first episode of psychosis to psychiatric services in south London, London, UK. Relapse of psychosis within 2 years after onset of psychosis was defined as risk of subsequent admission to hospital. We classified patients into different patterns of cannabis use based on continuity of use after onset of psychosis, potency of cannabis consumed, and frequency of use after the onset of their illness. We used multiple regression analyses (logistic or binominal) to compare the different cannabis use groups and propensity score analysis to validate the results.
Findings: Between April 12, 2002, and July 26, 2013, 256 patients presented with a first episode of psychosis. We did follow-up assessments for these patients until September, 2015. Simple analyses showed that former regular users of cannabis who stopped after the onset of psychosis had the most favourable illness course with regards to relapse. In multiple analysis, continued high-frequency users (ie, daily use in all 24 months) of high-potency (skunk-like) cannabis had the worst outcome, indexed as an increased risk for a subsequent relapse (odds ratio [OR] 3.28; 95% CI 1.22-9.18), more relapses (incidence rate ratio 1.77; 95% CI 0.96-3.25), fewer months until a relapse occurred (b -0.22; 95% CI -0.40 to -0.04), and more intense psychiatric care (OR 3.16; 95% CI 1.26-8.09) after the onset of psychosis.
Interpretation: Adverse effects associated with continued use of cannabis after the onset of a first episode of psychosis depend on the specific patterns of use. Possible interventions could focus on persuading cannabis-using patients with psychosis to reduce use or shift to less potent forms of cannabis.
Funding: National Institute for Health Research (NIHR).
FRANÇAIS :
La poursuite de la consommation de cannabis suite à l'apparition d'une psychose est associée à de pires résultats.
Lors d'une étude sur 256 patients ayant présenté un premier épisode de psychose, et suivis pendant deux ans, ceux qui étaient des consommateurs réguliers de cannabis avant l'apparition de la maladie ont pu améliorer le développement de leur maladie en arrêtant de consommer du cannabis. Ceux qui ont continué de consommer ont présenté un taux plus important de rechute. [IACM, 19/09/2016]
Background: Although cannabis use after a first episode of psychosis has been associated with relapse, little is known about the determinants of this most preventable risk factor for relapse of psychosis. Here we aimed to study whether the effects on outcome vary depending on the type of cannabis consumed and usage pattern.
Methods: In this observational study, we prospectively recruited and followed up patients aged 18-65 years who presented with their first episode of psychosis to psychiatric services in south London, London, UK. Relapse of psychosis within 2 years after onset of psychosis was defined as risk of subsequent admission to hospital. We classified patients into different patterns of cannabis use based on continuity of use after onset of psychosis, potency of cannabis consumed, and frequency of use after the onset of their illness. We used multiple regression analyses (logistic or binominal) to compare the different cannabis use groups and propensity score analysis to validate the results.
Findings: Between April 12, 2002, and July 26, 2013, 256 patients presented with a first episode of psychosis. We did follow-up assessments for these patients until September, 2015. Simple analyses showed that former regular users of cannabis who stopped after the onset of psychosis had the most favourable illness course with regards to relapse. In multiple analysis, continued high-frequency users (ie, daily use in all 24 months) of high-potency (skunk-like) cannabis had the worst outcome, indexed as an increased risk for a subsequent relapse (odds ratio [OR] 3.28; 95% CI 1.22-9.18), more relapses (incidence rate ratio 1.77; 95% CI 0.96-3.25), fewer months until a relapse occurred (b -0.22; 95% CI -0.40 to -0.04), and more intense psychiatric care (OR 3.16; 95% CI 1.26-8.09) after the onset of psychosis.
Interpretation: Adverse effects associated with continued use of cannabis after the onset of a first episode of psychosis depend on the specific patterns of use. Possible interventions could focus on persuading cannabis-using patients with psychosis to reduce use or shift to less potent forms of cannabis.
Funding: National Institute for Health Research (NIHR).
FRANÇAIS :
La poursuite de la consommation de cannabis suite à l'apparition d'une psychose est associée à de pires résultats.
Lors d'une étude sur 256 patients ayant présenté un premier épisode de psychose, et suivis pendant deux ans, ceux qui étaient des consommateurs réguliers de cannabis avant l'apparition de la maladie ont pu améliorer le développement de leur maladie en arrêtant de consommer du cannabis. Ceux qui ont continué de consommer ont présenté un taux plus important de rechute. [IACM, 19/09/2016]
Affiliation :
Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Autre(s) lien(s) :
Comment p. 909-910: http://www.sciencedirect.com/science/article/pii/S2215036616302309